Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Expert Synthesis Solutions (ESS) is a specialized contract research organization (CRO) that provides custom organic synthesis and medicinal chemistry services to the global pharmaceutical and biotechnology industries. Based in London, Ontario, the company focuses on the synthesis of complex organic molecules, including reference standards, drug metabolites, and impurities. ESS is particularly recognized for its expertise in producing stable isotope-labeled compounds, such as those containing Deuterium, Carbon-13, and Nitrogen-15, to support clinical and preclinical studies. Their services facilitate drug discovery and development by providing high-purity chemical entities and comprehensive analytical support. The company operates out of the Western Discovery Park, leveraging advanced laboratory facilities to meet the rigorous demands of life science researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Expert Synthesis Solutions.